dapsone has been researched along with tacrolimus in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rosenkrantz, WS | 1 |
| Dauendorffer, JN; Mahé, E; Saiag, P | 1 |
| Brieva, J; Ciurea, AM; Guitart, J | 1 |
| Bruckner-Tuderman, L; Büsing, V; Hofmann, SC; Kern, JS | 1 |
| Al-Mutairi, N | 1 |
| Frew, JW; Martin, LK; Murrell, DF | 1 |
| Georgakopoulou, EA; Scully, C | 1 |
| Allen, J; Chadwick, PR; Green, D; Lamerton, E; Middleton, R; Mitsides, N; New, D; Redshaw, J; Subudhi, CP; Wood, G | 1 |
| Bakkour, W; Chalmers, RJ; Chularojanamontri, L; Motta, L | 1 |
| Bakardzhiev, I; Chokoeva, AA; Krasnaliev, I; Lotti, T; Tana, C; Tchernev, G; Wollina, U | 1 |
| Aftab, M; Jain, S; Rai, A; Singh, AR; Singh, M | 1 |
| Gieler, U; Husein-ElAhmed, H; Steinhoff, M | 1 |
| Carley, SK; Kraus, CN; Lee, KH; Mesinkovska, NA | 1 |
| Karanfilian, KM; Wassef, C | 1 |
| Brinia, C; Gregoriou, S; Kontochristopoulos, G; Markantoni, V; Platsidaki, E; Rigopoulos, D; Tsiogka, A | 1 |
8 review(s) available for dapsone and tacrolimus
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pemphigus: current therapy.
Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Dog Diseases; Dogs; Glucocorticoids; Immunoglobulins, Intravenous; Mycophenolic Acid; Niacinamide; Organogold Compounds; Pemphigus; Sulfasalazine; Tacrolimus; Tetracycline | 2004 |
Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Dermatologic Agents; Epidermal Growth Factor; Evidence-Based Medicine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Medicine, Chinese Traditional; Mycophenolic Acid; Pemphigus; Pentoxifylline; Plasmapheresis; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2011 |
Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents.
Topics: Anti-Infective Agents; Calcineurin Inhibitors; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Drug Interactions; Drug Monitoring; Facial Dermatoses; Humans; Immunosuppressive Agents; Mouth Diseases; Tacrolimus; Thalidomide; Tubulin Modulators | 2015 |
Lichen planus: a comprehensive evidence-based analysis of medical treatment.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Antifungal Agents; Calcineurin Inhibitors; Calcitriol; Cyclosporine; Dapsone; Dermatologic Agents; Enoxaparin; Evidence-Based Medicine; Humans; Hydroxychloroquine; Lichen Planus; Methotrexate; Mycophenolic Acid; Retinoids; Tacrolimus; Ultraviolet Therapy | 2019 |
Treatment of erosive pustular dermatosis: a systematic review of the literature.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Infective Agents; Betamethasone; Calcineurin Inhibitors; Clobetasol; Dapsone; Dexamethasone; Glucocorticoids; Humans; Leg Dermatoses; Methylprednisolone; Photochemotherapy; Scalp Dermatoses; Tacrolimus | 2020 |
Erosive pustular dermatosis of the scalp: causes and treatments.
Topics: Acitretin; Adrenal Cortex Hormones; Aminolevulinic Acid; Anti-Infective Agents; Calcitriol; Dapsone; Dermatologic Agents; Humans; Immunosuppressive Agents; Isotretinoin; Keratolytic Agents; Photochemotherapy; Scalp Dermatoses; Tacrolimus | 2021 |
1 trial(s) available for dapsone and tacrolimus
| Article | Year |
|---|---|
Efficacy of steroidal vs non-steroidal agents in oral lichen planus: a randomised, open-label study.
Topics: Administration, Oral; Administration, Topical; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Female; Humans; Lichen Planus, Oral; Male; Retinoids; Tacrolimus; Treatment Outcome; Triamcinolone | 2017 |
15 other study(ies) available for dapsone and tacrolimus
| Article | Year |
|---|---|
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Tacrolimus ointment, an interesting adjunctive therapy for childhood linear IgA bullous dermatosis.
Topics: Administration, Topical; Chemotherapy, Adjuvant; Child, Preschool; Dapsone; Drug Resistance; Female; Humans; Immunosuppressive Agents; Ointments; Skin Diseases; Tacrolimus | 2008 |
Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone.
Topics: Anti-Infective Agents; Dapsone; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Pyoderma Gangrenosum; Tacrolimus | 2010 |
Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Cyclophosphamide; Dapsone; Dermatologic Agents; Desmoglein 3; Female; Humans; Immunosuppressive Agents; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Pemphigus; Tacrolimus; Treatment Outcome | 2010 |
Nosology and therapeutic options for lupus miliaris disseminatus faciei.
Topics: Adult; Dapsone; Drug Therapy, Combination; Facial Dermatoses; Female; Humans; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Prednisone; Tacrolimus; Treatment Outcome; Young Adult | 2011 |
Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought.
Topics: Adult; Aged; Anti-Infective Agents; Azathioprine; Cohort Studies; Cyclosporine; Dapsone; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Length of Stay; Male; Methemoglobinemia; Middle Aged; Mycophenolic Acid; Pneumonia, Pneumocystis; Prednisolone; Prevalence; Regression Analysis; Risk Factors; Tacrolimus | 2014 |
Successful use of dapsone for the management of circinate balanitis.
Topics: Balanitis; Dapsone; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Tacrolimus; Treatment Outcome; Young Adult | 2014 |
Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Biopsy; Chloroquine; Combined Modality Therapy; Dapsone; Diagnosis, Differential; Humans; Hydroxychloroquine; Lasers, Dye; Lupus Erythematosus, Discoid; Male; Ointments; Quinacrine; Skin; Sunscreening Agents; Tacrolimus | 2016 |
Amicrobial pustulosis of the folds: long-term remission achieved with low dose dapsone and topical pimecrolimus.
Topics: Dapsone; Humans; Skin Diseases; Tacrolimus | 2023 |